Article

Hypersensitivity for capsaicin in patients with functional dyspepsia

Abteilung für Gastroenterologie und Hepatologie, Medical University of Vienna, Vienna, Austria.
Neurogastroenterology and Motility (Impact Factor: 3.42). 03/2008; 20(2):125-33. DOI: 10.1111/j.1365-2982.2007.00997.x
Source: PubMed

ABSTRACT The pathophysiology of functional dyspepsia is poorly understood, thus diagnostic and therapeutic options for this disease are limited. We assessed the relevance of a simple test for chemical hypersensitivity by applying an oral capsaicin load. After a preliminary dose-finding study, 61 healthy controls and 54 functional dyspepsia patients swallowed a capsule containing 0.75 mg capsaicin. A graded questionnaire evaluated severity of symptoms before and after capsule ingestion; an aggregate symptom score was calculated by adding all symptom scores. Controls developed moderate symptoms (symptom score: 6.0+/-4.1; median: 5.0). The 75% quartile (9.0) was considered the upper limit of normal. Functional dyspepsia patients had significantly higher symptom scores (10.0+/-6.5) than controls. About 54% of functional dyspepsia patients tested positive; clinically this group was not different from the group testing negative besides being on average younger and suffering more from bloating. In additional 13 patients with functional dyspepsia who tested positive (symptom score: 15.8+/-0.9), symptom response to placebo capsules (1.9+/-0.6) was similar to controls. In reliability testing, the Cronbach alpha-value of the capsaicin test was 0.86. The capsaicin test is a simple and non-invasive method to detect a subgroup of functional dyspepsia with chemical hypersensitivity.

Download full-text

Full-text

Available from: Johannes Matiasek, Nov 08, 2014
0 Followers
 · 
216 Views
  • Source
    • "Upregulation of TRPV1 in the mucosa, with a correlation to pain sensitivity in irritable bowel syndrome and in inflammatory bowel disease with irritable bowel syndrome-like symptoms Facer et al., 2001; Yiangou et al., 2001; Chan et al., 2003; Matthews et al., 2004; Bhat & Bielefeldt, 2006; Akbar et al., 2008, 2010; Guarino et al., 2010; Shieh et al., 2010 Esophagus, stomach, intestine and pancreas Acid-induced oesophagitis, gastric acidevoked injury of the stomach, trinitrobenzene sulfonic acid-induced pancreatitis and colitis in rodents Upregulation of TRPV1 in vagal and spinal afferent neurons Schicho et al., 2004; Banerjee et al., 2007; Miranda et al., 2007; Xu et al., 2007 Esophagus, stomach and small intestine Abdominal pain in human volunteers Induction by intraluminal capsaicin Schmidt et al., 2004; Hammer, 2006a, 2006b; Hammer & Vogelsang, 2007; Hammer et al., 2008; Führer & Hammer, 2009; Kindt et al., 2009; Chen et al., 2010; van Boxel et al., 2010 Stomach Behavioral pain response to intragastric acid challenge in rats Prevention by TRPV1 antagonism Lamb et al., 2003 Stomach and upper small intestine Functional dyspepsia Hypersensitivity to the algesic effect of capsaicin Hammer et al., 2008 Stomach and upper small intestine Functional dyspepsia Beneficial effect of 5 week ingestion of capsaicin capsules Bortolotti et al., 2002 Duodenum Pain sensitivity to capsaicin exposure and balloon distension in humans "
    [Show abstract] [Hide abstract]
    ABSTRACT: Approximately 20 of the 30 mammalian transient receptor potential (TRP) channel subunits are expressed by specific neurons and cells within the alimentary canal. They subserve important roles in taste, chemesthesis, mechanosensation, pain and hyperalgesia and contribute to the regulation of gastrointestinal motility, absorptive and secretory processes, blood flow, and mucosal homeostasis. In a cellular perspective, TRP channels operate either as primary detectors of chemical and physical stimuli, as secondary transducers of ionotropic or metabotropic receptors, or as ion transport channels. The polymodal sensory function of TRPA1, TRPM5, TRPM8, TRPP2, TRPV1, TRPV3 and TRPV4 enables the digestive system to survey its physical and chemical environment, which is relevant to all processes of digestion. TRPV5 and TRPV6 as well as TRPM6 and TRPM7 contribute to the absorption of Ca²⁺ and Mg²⁺, respectively. TRPM7 participates in intestinal pacemaker activity, and TRPC4 transduces muscarinic acetylcholine receptor activation to smooth muscle contraction. Changes in TRP channel expression or function are associated with a variety of diseases/disorders of the digestive system, notably gastro-esophageal reflux disease, inflammatory bowel disease, pain and hyperalgesia in heartburn, functional dyspepsia and irritable bowel syndrome, cholera, hypomagnesemia with secondary hypocalcemia, infantile hypertrophic pyloric stenosis, esophageal, gastrointestinal and pancreatic cancer, and polycystic liver disease. These implications identify TRP channels as promising drug targets for the management of a number of gastrointestinal pathologies. As a result, major efforts are put into the development of selective TRP channel agonists and antagonists and the assessment of their therapeutic potential.
    Pharmacology [?] Therapeutics 03/2011; 131(1):142-70. DOI:10.1016/j.pharmthera.2011.03.006 · 7.75 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In dit proefschrift worden nieuwe inzichten over de pathofysiologie en behandeling van gastro-oesofageale refluxziekte (GORZ) en functionele dyspepsie (FD) besproken. Zoals bekend ligt met betrekking tot de pathofysiologie van GORZ de nadruk vooral op de blootstelling van de slokdarm aan maaginhoud. Bij FD staat meer het vomen van motorische en sensorische stoornissen van de maag op de voorgrond. Bij zowel GORZ als FD zijn er echter aanwijzingen dat ook viscerale hypersensitiviteit en centrale sensitisatie kunnen bijdragen aan de pathofysiologie. Bij beide aandoeningen versterkt infusie van vet in het duodenum de perceptie van prikkels uit andere delen van het maag-darmstelsel. Het mogelijke onderliggende mechanisme werd onderzocht door de expressie van genen, betrokken bij vetabsorptie, in biopten uit het duodenum en tevens de concentraties van de signaleringseiwitten (CCK en apoA-IV) te meten na duodenale vetinfusie bij zowel patiënten als gezonde vrijwilligers. Mucosale eiwitconcentraties in patiënten waren lager dan in gezonde vrijwilligers. Tevens kwamen twee genen verhoogd tot expressie bij GORZ patiënten. Deze resultaten suggereren dat de afgifte van signaleringseiwitten verhoogd is bij patiënten en dat deze eiwitten in het duodenum kunnen zorgen voor aanhoudende prikkeling van de perifere zenuwuiteinden waardoor vervolgens centrale sensitisatie optreedt. Daarnaast werd de invloed van sociaal economische status (SES) van patiënten op chronisch protonpompremmer (PPI)-gebruik in Nederland onderzocht. In deze studies kwam naar voren dat patiënten met een lage SES vaker PPI’s gebruikten dan patiënten met een hogere SES. Ook werd aangetoond dat, ondanks de richtlijnen, meer dan 50% van de NSAID-gebruikers met minimaal 驮 risicofactor voor maagschade geen PPI voorgeschreven kreeg. Dit leek te worden beïnvloed door sociodemografische factoren van zowel de arts als de patiënt. Tenslotte hebben we de mogelijke associatie tussen gelijktijdig PPI- en clopidogrel-gebruik en het vomen van cardiovasculaire complicaties onderzocht. Nieuwe clopidogrel gebruikers die gelijktijdig een PPI voorgeschreven kregen, bleken een verhoogd risico op cardiovasculaire en gastrointestinale complicaties te hebben vergeleken met de groep zonder PPI. Het inferieure cardiovasculaire risicoprofiel van PPI-gebruikers en het vomen van channeling bias zijn belangrijke factoren die ten grondslag liggen aan deze bevindingen.
  • [Show abstract] [Hide abstract]
    ABSTRACT: This mini-review addresses the role of the neuroendocrine substance serotonin (5-hydroxytryptamine, 5-HT) in intestinal luminal sensing and secretion. Intestinal sensory neurones are activated by several mechanisms, in particular following stimulation of 'specialized' cells in the mucosa. These specialized cells are the enteroendocrine cells, which contain a wide variety of neuroendocrine transmitters. One of these enteroendocrine cells is the enterochromaffin (EC) cell, which is present throughout the intestines and contains large amounts of serotonin, predominantly in the duodenum in humans. The EC cells act as mucosal sensory transducers and secrete serotonin in response to various physiological and pathological luminal stimuli. Following release, serotonin participates in several mucosal protecting processes, one being secretion. Serotonin stimulates active ion, mucus and fluid secretion. Epithelial 5-HT(2) receptors and neuronal 5-HT(1P), 5-HT(3) and 5-HT(4) receptors mediate the secretory effect of serotonin. A transmembrane serotonin transporter terminates epithelial serotonergic signalling. The transient receptor potential ion channel family is important for processing intestinal luminal sensory signalling. Accumulating evidence suggests a significant interaction between serotonin and one of the transient receptor potential ion channels, the capsaicin-sensitive transient receptor potential vanilloid type 1. Accordingly, EC cells, serotonergic receptors and transporter(s), and transient receptor potential vanilloid type-1 ion channels are all explored as pharmacological targets for treatment of some intestinal functional disorders.
    Acta Physiologica 06/2008; 193(4):311-23. DOI:10.1111/j.1748-1716.2008.01870.x · 4.25 Impact Factor
Show more